You are here

Justice News

Department of Justice
U.S. Attorney’s Office
Eastern District of Virginia

Tuesday, May 22, 2018

Former Medical Assistant Pleads Guilty to Distributing Oxycodone

ALEXANDRIA, Va. – A Woodbridge woman pleaded guilty today to conspiring with others to distribute oxycodone.

According to court documents, Tatiana Bailey, 31, was employed as a medical assistant at INOVA Bariatric Surgery Medical Practice from at least February 2015 to October 2015, where she had access to blank prescriptions. On multiple occasions, Bailey stole blank oxycodone prescriptions and forged some of them using an INOVA doctor’s name and registration number. She then sold blank and forged prescriptions to others who would fill them and use or distribute the oxycodone. Through the course of the conspiracy, Bailey facilitated the fraudulent filling of over 90 prescriptions, totaling approximately 6,520 oxycodone pills.

Bailey pleaded guilty to conspiracy to distribute controlled substances and faces a maximum penalty of 20 years in prison when sentenced on September 28. Actual sentences for federal crimes are typically less than the maximum penalties.  A federal district court judge will determine any sentence after taking into account the U.S. Sentencing Guidelines and other statutory factors.

Tracy Doherty-McCormick, Acting U.S. Attorney for the Eastern District of Virginia, Karl C. Colder, Special Agent in Charge for the Drug Enforcement Administration’s (DEA) Washington Field Division, and Colonel Gary T. Settle, Virginia State Police Superintendent, made the announcement after U.S. District Judge Liam O’Grady accepted the plea.  Special Assistant U.S. Attorneys Allison Garnett and Troy A. Edwards, Jr. are prosecuting the case.

A copy of this press release is located on the website of the U.S. Attorney’s Office for the Eastern District of Virginia.  Related court documents and information is located on the website of the District Court for the Eastern District of Virginia or on PACER by searching for Case No. 1:18-cr-222.

Prescription Drugs
Joshua Stueve Director of Communications
Updated May 23, 2018